scholarly article | Q13442814 |
P50 | author | Nagalingeswaran Kumarasamy | Q63142619 |
Yi-Ming Arthur Chen | Q66739728 | ||
Somnuek Sungkanuparph | Q75156091 | ||
Praphan Phanuphak | Q90051565 | ||
Sanjay Pujari | Q91153560 | ||
Fujie Zhang | Q101133134 | ||
Rossana Ditangco | Q114446763 | ||
Jun Yong Choi | Q40143606 | ||
Adeeba Kamarulzaman | Q55950718 | ||
P2093 | author name string | Shinichi Oka | |
Saphonn Vonthanak | |||
Matthew G Law | |||
Man Po Lee | |||
Christopher K C Lee | |||
Jialun Zhou | |||
Patrick C K Li | |||
Poh Lian Lim | |||
Thira Sirisanthana | |||
Jeffery Smith | |||
Preeyaporn Srasuebkul | |||
Tuti P Merati | |||
Goa Tau | |||
P2860 | cites work | A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study | Q57877926 |
HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting | Q58064891 | ||
Compliance with public sector HIV medical care | Q72576293 | ||
Potential factors affecting adherence with HIV therapy | Q73916433 | ||
Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational Database | Q79350864 | ||
Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database | Q79788120 | ||
Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa | Q79914432 | ||
AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database | Q80595030 | ||
CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients | Q82424050 | ||
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults | Q28184343 | ||
Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy | Q30947115 | ||
The TREAT Asia HIV Observational Database: baseline and retrospective data | Q30981390 | ||
Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data | Q31005220 | ||
Predictors of disease progression in HIV infection: a review | Q35834337 | ||
Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD). | Q36102478 | ||
Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997. | Q36456768 | ||
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. | Q37104874 | ||
Natural history of human immunodeficiency virus infection and key predictors of HIV disease progression | Q38216753 | ||
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors | Q39605793 | ||
External validation is necessary in prediction research: a clinical example | Q40549827 | ||
Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation | Q40936398 | ||
Survivor treatment selection bias in observational studies: examples from the AIDS literature | Q40983015 | ||
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group | Q43656441 | ||
Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi | Q43876514 | ||
Anemia and survival in human immunodeficiency virus | Q43894912 | ||
More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts | Q44939368 | ||
Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection | Q44964641 | ||
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries | Q46391119 | ||
Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients | Q47601725 | ||
Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS. | Q50858852 | ||
Practical experiences on the necessity of external validation. | Q51904901 | ||
Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD). | Q51974610 | ||
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score. | Q53532256 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | database | Q8513 |
HIV | Q15787 | ||
anti-retroviral agent | Q50430310 | ||
P304 | page(s) | 940-950 | |
P577 | publication date | 2009-04-01 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database | |
P478 | volume | 48 |
Q35852326 | Advanced HIV Disease at Enrolment in HIV Care: Trends and Associated Factors over a Ten Year Period in Cambodia |
Q34813110 | An internationally generalizable risk index for mortality after one year of antiretroviral therapy. |
Q34183235 | Anaemia in pregnancy is associated with advanced HIV disease |
Q33986542 | Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia |
Q40860723 | Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts |
Q34056735 | Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa |
Q26828045 | Nutrition assessment, counseling, and support interventions to improve health-related outcomes in people living with HIV/AIDS: a systematic review of the literature |
Q37343891 | Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program |
Q37028220 | Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: results from the TREAT Asia HIV observational database |
Q42216147 | Prevalence and predictors of anaemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China |
Q37168581 | Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings |
Q58084945 | Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort |
Q34556999 | Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic |
Search more.